CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
5 stories
🇧🇷 Folha (PT)
National & Local

Even with urgency approved, Motta is expected to delay analysis of the 'Monjauro PL'

The bill aimed at breaking the patent of Monjauro and Zepbound is likely to be delayed until after mid-March, despite urgency approval.

Feb 23 • 21:30 UTC
🇧🇷 G1 (PT)
National & Local

Alckmin says he is against a bill that provides for the breaking of patents of weight loss pens

Brazil's Vice President Geraldo Alckmin expressed opposition to a legislative bill aimed at breaking patents for weight loss pens, Mounjaro and Zepbound, arguing it would deter investment and innovation.

Feb 12 • 21:04 UTC
🇧🇷 Folha (PT)
National & Local

Chamber approves urgent processing of project that breaks the patent of Mounjaro

The Brazilian Chamber of Deputies approved an urgent bill to declare the medications Mounjaro and Zepbound as of 'public interest', facilitating the national production by breaking their patents.

Feb 9 • 22:37 UTC
🇧🇷 Folha (PT)
National & Local

Chamber approves urgent processing for project that breaks the patent of Mounjaro

The Brazilian Chamber of Deputies has approved an urgent requirement for a bill that allows the breaking of patents for the drugs Mounjaro and Zepbound, declaring them as of 'public interest' for national production.

Feb 9 • 22:37 UTC
🇮🇹 La Repubblica
Life & Tech

Serena Williams in a Super Bowl ad injects a weight-loss drug: and there’s controversy

Serena Williams appears in a Super Bowl advertisement promoting a weight-loss drug, sparking controversy over the implications of using such a product and its influence on body image.

Feb 9 • 17:04 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.